Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 826.25 billion as of April 28, 2026. Its market cap has increased by 28.70% in one year.

Market Cap

826.25B

Enterprise Value

815.20B

Revenue

331.82B

Ranking

n/a

PE Ratio

23.70

Stock Price

1,421.30

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 826.25B, an increase of 8,503.82%. That is a compound annual growth rate of 20.55%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	826.25B	20.25%
Dec 31, 2025	687.09B	-11.35%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lupin	1,049.73B
Dr. Reddy's Laboratories	1,095.57B
Abbott India	535.45B
Torrent Pharmaceuticals	1,392.97B
GlaxoSmithKline Pharmaceuticals	418.95B
J. B. Chemicals & Pharmaceuticals	321.75B
AstraZeneca Pharma India	212.54B
Granules India	170.76B

Market Cap Rankings